The Importance of Scale in Evaluating the Gut Microbiome

In a recent study performed by prof. Peter Malfertheiner the aim was to analyze the levels of two different types of antibodies (anti-CdtB/anti-vinculin) in patients with Functional Gastrointestinal Disorders (FGID) and in healthy controls and to associate the serological findings with the composition of fecal microbiota and the level of dysbiosis. Microbiota analysis and assessment of dysbiosis were performed in fecal samples using the GA-map® Dysbiosis Test Lx.

The study cohort included 43 FGID patients and 22 healthy controls. FGID subgroups were defined according to Rome III criteria. 

Please follow the link to read the interview with prof. Peter Malfertheiner on the study: